Discovery of new drug may release immune cells destroy cancer cells – Harvard Gazette
Harvard Gazette |
Discovery of new drug may release immune cells destroy cancer cells
Harvard Gazette “PD-1 checkpoint inhibitors have transformed the treatment of many cancers, and opened the door to the possibility that immunotherapy will form part of the cure for cancer,” says Haining, senior author on the new paper, who is also associate professor … |
Medical Xpress |
Novel CRISPR-Cas9 screening enables discovery of new targets to …
Medical Xpress A novel screening method developed by a team at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing … |
|
FDA Advisory Committee Recommends Approval of CAR–T Cell Therapy and Two New Biosimilars
Lexology (registration) The FDA’s Oncologic Drug Advisory Committee (“ODAC”) held a public meeting on Wednesday, July 12, 2017, to consider Novartis’ biologic license application (BLA 125646) for tisagenlecleucel (CTL019), an investigational chimeric antigen receptor T cell … |
IFLScience |
Promising Treatment For Leukemia Leads To Remission In Clinical …
IFLScience An exciting therapy for leukemia once again shines a light on its efficacy – this time, nearly 71 percent of terminal leukemia patients saw their tumors sh. |
LancasterOnline |
McCaskey grad writes new book on CRISPR and genome engineering
LancasterOnline Now, the McCaskey High graduate has co-written a new book about gene editing and CRISPR. “A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution” was written by microbiologist Jennifer Doudna and Sternberg. The book … |
LancasterOnline |
McCaskey grad writes new book on CRISPR and genome engineering
LancasterOnline Now, the McCaskey High graduate has co-written a new book about gene editing and CRISPR. “A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution” was written by microbiologist Jennifer Doudna and Sternberg. The book … |
Independent.ie |
‘Tragic and avoidable’ – Hospital apologises for death of woman after stem cell operation
Independent.ie Ms Kozyra needed the transplant having been diagnosed at Belfast City Hospital with a bone marrow stem cell disorder. A family match could not be found for her and Northern Ireland does not carry out unrelated donor bone marrow transplants. So she was … |
FierceBiotech |
News of Note—Dodgy stem cell clinics; New CMO for Context; UroGen payday
FierceBiotech In an article published today in the journal Regenerative Medicine, it turns out that the federal clinical-trials database ClinicalTrials.gov has allowed 18 ostensible clinical trials of unregulated stem cell therapies, that patients must to pay to … |